Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years Old

Patients aged less than 18-y with validated 8% capsaicin patch treatment in routine healthcare will be offered to participate the study. If they accept it as well as their parents, they will be included in the study . Medical data will be recorded and at home, the child or his family will collect pain assessment data. Tolerance will be monitored at home by phone call from investigational team every 24 hours until normalization. (Less than 24 hours for 75%, 100% to 72 hours on unpublished personal series.) Children will be assessed via scales at inclusion and 1-month, 3-month and 6-month.

NCT Number	NCT05299294
Lead Sponsor	University Hospital, Brest Collaborators: Fondation de France, Fondation Apicil
Conditions	Neuropathic Pain, Chronic Pain
Enrollment	160 participants
Start Date	2022-05-12
Primary Completion	2027-05 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-30